SwapnaThotaMD

PubMed

• Immune Checkpoint Inhibitor Therapy and Associations with Clonal Hematopoiesis.
  Abhay Singh, Nuria Mencia Trinchant, Rahul Mishra, Kirti Arora, Smit Mehta
  International Journal of Molecular Sciences. 2024-10-15
• 46 citations
  Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
  Daniel A Pollyea, Jessica K Altman, Rita Assi, Dale Bixby, Amir T Fathi
  Journal of the National Comprehensive Cancer Network. 2023-05-01
• 1 citations
  Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.
  Amanda Przespolewski, Aaron D Goldberg, Chetasi Talati, Salman Fazal, Pankit Vachhani
  Blood. 2023-03-23

Abstracts/Posters

• Benefits of a Pharmacist Led Oral Chemotherapy Monitoring Program for Patients with Chronic Myeloid Malignancies: A Patient Reported Outcome (PRO) Study
  Swapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor ± Mitoxantrone (CLAG ± M) Is Highly Effective Therapy for Secondary and Relapsed/Refractory Acute Myeloid...
  Swapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• De Novo and Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome: Similarities and Differences in SNP-Array Detected Chromosomal Aberrations in Pre-Tran...
  Swapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcomes of Venetoclax-Based Regimens Compared with Hypomethylating Agents (HMA) Alone or 7+3 in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): A ...
  Swapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Quantification of Humoral Immune Response to Influenza Vaccination in MDS
  Swapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Outcomes of AML Patients Treated with Gemtuzumab-Ozogamicin Based Therapies: A Cue to Optimal Chemotherapy Backbone 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Clinical Outcomes for Patients with Myeloid Malignancies Harboring IDH1/2mutations after Intensive Chemotherapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018